Sort
82,697 grants matching “vaccine development”
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$716,901James L. Sorensen · University Of California, San Francisco · UG1 · FY2016 · DA
Chikungunya Virus Replication and Pathogenesis
$716,844Terence S. Dermody · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
Production and purification of biological compounds
$716,829Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2020 · DK
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei
$716,802Biao He · University Of Georgia · R01 · FY2018 · AI
Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection
$716,728Marian L Kohut · Iowa State University · R01 · FY2024 · AI
Genetics of Coxiella burnetii
$716,704Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Mechanisms Underlying Persistent Lentivirus Replication in Follicular T Cells
$716,691Elizabeth Connick · University Of Colorado Denver · R01 · FY2014 · AI
Fusion inhibitors that block host-to-host transmission of SARS-CoV-2
$716,622Matteo Porotto · Columbia University Health Sciences · R01 · FY2022 · AI
Structure And Assembly Of The Hepatitis B Nucleocapsid Protein
$716,592Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2009 · AR
Chemoprophylaxis for HIV Prevention in Men Supplement
$716,590Robert M. Grant · J. David Gladstone Institutes · U01 · FY2007 · AI
Administrative
$716,589Douglas D Richman · University Of California, San Diego · P30 · FY2014 · AI
Expanding Patient Engagement in Diabetes Care: Patient Portal Innovation
$716,535William Martinez · Vanderbilt University Medical Center · R18 · FY2020 · DK
The longer-term impact of prenatal exposure to SARS-CoV-2 infection and the COVID-19 vaccine on behavior, cognition, and brain functioning in the child
$716,474Anna-Sophie Rommel · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HD
HIV-1 Genetic Variation in Infected Individuals
$716,453Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
FcRn-targeted mucosal HIV vaccine
$716,450Charles David Pauza · University Of Maryland Baltimore · R01 · FY2013 · AI
Practices Core
$716,336William Paul Duprex · University Of Pittsburgh At Pittsburgh · UC7 · FY2025 · AI
ADOLESCENT MEDICINE TRIALS UNIT
$716,236Donna Futterman · Montefiore Medical Center (Bronx, Ny) · U01 · FY2007 · HD
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever
$716,197Jinhong Chang · Baruch S. Blumberg Institute · R01 · FY2020 · AI
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses
$716,192Harvinder Singh Gill · Texas Tech University · R01 · FY2019 · AI
Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection
$716,177Marian L Kohut · Iowa State University · R01 · FY2023 · AI
Vaccines Against Botulism
$716,173Joseph T. Barbieri · Medical College Of Wisconsin · R01 · FY2020 · AI
Discovery of new cellular targets for small-molecule inhibition of enveloped vir
$716,172Sean P. J. Whelan · Harvard Medical School · U19 · FY2015 · AI
Targeting 5' leader-encoded defective ribosomal products for HIV T cell vaccines
$716,155George M Shaw · University Of Pennsylvania · R01 · FY2017 · AI
Core--Primate
$716,138Christopher Miller · University Of California At Davis · P01 · FY2008 · AI
Characteristics and protective efficacy of human antibodies against M. tuberculosis
$716,093Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R01 · FY2023 · AI